NovaBay Pharmaceuticals, Inc. (NBY)
NYSEAMERICAN: NBY · Real-Time Price · USD
0.681
-0.039 (-5.42%)
At close: Nov 22, 2024, 4:00 PM
0.671
-0.010 (-1.42%)
After-hours: Nov 22, 2024, 7:34 PM EST
NovaBay Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -10.12 | -9.64 | -10.61 | -5.82 | -11.04 | -9.66 | |
| Depreciation & Amortization | 0.23 | 0.2 | 0.48 | 0.12 | 0.05 | 0.07 | |
| Other Amortization | 1.44 | 1.69 | - | - | 0.14 | 0.69 | |
| Loss (Gain) From Sale of Assets | 0.87 | - | - | - | 0 | 0 | |
| Asset Writedown & Restructuring Costs | 2.6 | 2.6 | 6.8 | - | - | 0.16 | |
| Stock-Based Compensation | 0.23 | 0.29 | 0.22 | 1.17 | 0.75 | 0.73 | |
| Other Operating Activities | 0.29 | -0.02 | -4.09 | -4.62 | 5.16 | -1.11 | |
| Change in Accounts Receivable | 0.28 | 1.21 | -0.31 | 0.45 | -0.32 | 2.32 | |
| Change in Inventory | 0.84 | 0.56 | -0.22 | -0.24 | -0.12 | -0.21 | |
| Change in Accounts Payable | -0.4 | -1.16 | 0.67 | -0.16 | 0.32 | -1.84 | |
| Change in Other Net Operating Assets | -0.07 | 0.13 | 0.39 | -0.08 | 0.32 | 0.94 | |
| Operating Cash Flow | -4.73 | -4.13 | -6.65 | -9.19 | -4.72 | -7.93 | |
| Capital Expenditures | -0.01 | -0.02 | -0.11 | -0.05 | -0.03 | -0.02 | |
| Cash Acquisitions | - | - | - | -11.99 | - | - | |
| Investing Cash Flow | 1.06 | -0.02 | -0.11 | -12.05 | -0.03 | -0.02 | |
| Short-Term Debt Issued | - | 3 | - | 0.11 | - | 3 | |
| Total Debt Issued | - | 3 | - | 0.11 | - | 3 | |
| Short-Term Debt Repaid | - | -1.47 | -0.11 | - | -2.56 | -0.65 | |
| Total Debt Repaid | -2.69 | -1.47 | -0.11 | - | -2.56 | -0.65 | |
| Net Debt Issued (Repaid) | -2.69 | 1.53 | -0.11 | 0.11 | -2.56 | 2.35 | |
| Issuance of Common Stock | 3.67 | 0.57 | 1.7 | 1.78 | 12.33 | 6.96 | |
| Other Financing Activities | -0 | -0.18 | - | - | - | -0.2 | |
| Financing Cash Flow | 0.97 | 1.91 | 4.63 | 16.79 | 9.76 | 11.7 | |
| Net Cash Flow | -2.4 | -2.24 | -2.13 | -4.45 | 5.02 | 3.75 | |
| Free Cash Flow | -4.74 | -4.15 | -6.77 | -9.24 | -4.75 | -7.95 | |
| Free Cash Flow Margin | -34.23% | -28.18% | -46.97% | -90.59% | -47.79% | -120.44% | |
| Free Cash Flow Per Share | -3.28 | -34.46 | -147.09 | -259.45 | -165.79 | -449.90 | |
| Cash Interest Paid | 0.3 | 0.33 | 0.02 | - | 0.05 | 0.15 | |
| Cash Income Tax Paid | 0.36 | 0.36 | 0.02 | 0.02 | 0.01 | 0.01 | |
| Levered Free Cash Flow | 0.36 | -0.17 | -3.85 | -6.96 | -2.67 | -3.14 | |
| Unlevered Free Cash Flow | -1.08 | -1.86 | -3.85 | -6.96 | -2.81 | -3.82 | |
| Change in Net Working Capital | -1.97 | -0.79 | -0.36 | 2.66 | -0.43 | -1.28 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.